Home › Marginal Zone Lymphoma › California › Los Angeles
Marginal Zone Lymphoma clinical trials in Los Angeles, CA
4 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of ARC-02 in B-cell NHL
RecruitingPhase 1
- Start Cala, Los Angeles
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma
RecruitingPhase 3
- David Geffen School of Medicine at UCLA, Los Angeles
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RecruitingPhase 1/2
- Valkyrie Clinical Trials, Los Angeles
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
RecruitingPhase 1
- START Los Angele, Los Angeles
Marginal Zone Lymphoma trials in other cities
- Durham, NC12 studies
- New York City, NY11 studies
- Seattle, WA9 studies
- Boston, MA9 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Rochester, MN8 studies
- Houston, TX8 studies
- Columbus, OH8 studies
- Edison, NJ8 studies
- Miami, FL7 studies
- Nashville, TN7 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.